2016 HEADLINES- Archives -
John Landers, PhD, led a team of more than 80 scientists who found that variations in a gene with multiple functions in neurons are present in approximately 3 percent of all cases of ALS in North American and European populations, both sporadic and familial.
On Match Day, 116 students from the School of Medicine Class of 2016 discovered where they will spend their residencies, with 81 students representing 68 percent of the class entering primary care.
Shan Lu, MD, PhD, has received $17.3 million from the National Institute of Allergy and Infectious Diseases to develop and produce an optimized HIV vaccine to be used in Phase II human clinical trials.
Top Story: Viral infection during pregnancy causes autism-like behaviors in mice by triggering key immune reaction
A new study found that activation of a particular immune response in pregnant mice alters the brain structure of the mouse offspring and causes behavioral changes reminiscent of those observed in humans with autism. The research was published in Science. Jun Huh, PhD, is a corresponding author.
Vladimir Litvak, PhD, and colleagues made a startling discovery that immune system signaling can directly affect social behavior. Published in Nature, these findings could have great implications for neurological diseases such as autism-spectrum disorders and schizophrenia.
UMass Medical School and UMass Memorial Health Care have announced that Mary Maloney, MD, professor of medicine and director of dermatologic surgery, will serve as interim chair of the newly created Department of Dermatology.
Study co-authored by Jean King finds early life exposure to social stress changes brain connectivity
Scientists at UMass Medical School and the Cummings School of Veterinary Medicine at Tufts University found that exposure to social stressors early in life can change active portions of the brain linked to social behavior, stress, emotion and depression. The study, published in Behavioural Brain Research, was co-authored by Jean King, PhD.
The bionic pancreas system developed by Boston University investigators and tested at four academic medical centers, including UMass Medical School, proved better than either conventional or sensor-augmented insulin pump therapy, according to a new report of a clinical trial published in The Lancet. David M. Harlan, MD, oversaw the clinical trial at UMMS and is a co-author on the new paper.
The Commonwealth of Massachusetts has been named a partner in the nation’s first manufacturing innovation institute in biopharmaceutical manufacturing, and UMass Medical School is one of five universities supporting the effort.
PhD candidate Aimee Kroll-Desrosiers was awarded the 2016 Charles E. Gibbs Leadership Prize by Women’s Health Issues for research that examined opioid use during pregnancy by women veterans.